Literature DB >> 15138913

Intrathecal baclofen in pain management.

Marc Slonimski1, Stephen E Abram, Robert E Zuniga.   

Abstract

Baclofen is a GABA(B) agonist that is administered spinally via an implanted drug delivery device to treat spasticity. It has been shown to have powerful antinociceptive effects in experimental animal models at doses that produce little or no motor-blocking effects but has rarely been used as a spinal analgesic agent in patients without spasticity. Several studies have indicated that intrathecal baclofen provides relief of central pain in patients with spasticity. To date, only 3 studies have shown it to be effective in patients with peripheral nociceptive or neuropathic pain mechanisms. Combinations of baclofen and morphine or clonidine are more effective than each drug alone in clinical as well as animal studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138913     DOI: 10.1016/j.rapm.2004.01.005

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  19 in total

1.  Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity.

Authors:  S A Sadiq; C A Poopatana
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

Review 2.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 3.  GABA pharmacology: the search for analgesics.

Authors:  Kenneth E McCarson; S J Enna
Journal:  Neurochem Res       Date:  2014-02-15       Impact factor: 3.996

4.  Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.

Authors:  M Kalinichev; T Donovan-Rodriguez; F Girard; E Riguet; M Rouillier; B Bournique; H Haddouk; V Mutel; S Poli
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy.

Authors:  Xiu-Li Wang; Hong-Mei Zhang; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Physiol       Date:  2007-01-11       Impact factor: 5.182

Review 6.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Ayikoe G Mensah-Nyagan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

Review 8.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

9.  Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2010-08-03

10.  Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo.

Authors:  Vijayan Gangadharan; Nitin Agarwal; Stefan Brugger; Imgard Tegeder; Bernhard Bettler; Rohini Kuner; Martina Kurejova
Journal:  Mol Pain       Date:  2009-11-19       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.